Upload
others
View
9
Download
0
Embed Size (px)
Citation preview
Supporting Information
Copper-Catalyzed Propargylation of DiborylmethaneFeng Li, Zhen-Qi Zhang, Xi Lu, Bin Xiao,*Yao Fu*
Hefei National Laboratory for Physical Sciences at the Microscale, iChEM, CAS Key Laboratory of Urban Pollutant Conversion, Anhui Province Key Laboratory of Biomass Clean Energy, University of Science and Technology of China, Hefei
230026, China.
Table of Contents
I. General Information……………………..……………………………P2
II. Preparation of Substrates…………………………………………P3-P4
III. Copper-Catalyzed Propargylation of Diborylmethane….…P5-P17
IV. References……………….………………….…………………………………P18
V. Spectral data…………………………....…………………………………P19-P70
Page S1
Electronic Supplementary Material (ESI) for ChemComm.This journal is © The Royal Society of Chemistry 2017
Supporting Information
I. General Informationa. Materials All reactions were carried out in oven-dried Schlenk tubes under an argon or nitrogen
atmosphere (purity ≥99.999%). The following chemicals were purchased and used as
received: LiOtBu (J&K), LiOMe (J&K). Anhydrous THF (Acros), anhydrous Toluene
(Acros), anhydrous Dioxane (Acros), anhydrous DMSO (Acros), and anhydrous
CH3CN (Acros), and Dibromomethane-d2 (Aldrich) were stored over 4 Å molecular
sieves under an argon atmosphere in a septum-capped bottle. All other reagents and
solvents mentioned in this text were purchased from commercial sources and used
without purification.
b. Analytical Methods1H, 11B and 13C spectra were recorded either on Bruker Avance 400 or Varian
Mercury 400 spectrometer at ambient temperature in CDCl3 unless otherwise noted;
11B NMR signals are quoted relative to BF3Et2O. Data for 1H-NMR are reported as
follows: chemical shift (δ ppm), multiplicity, integration, and coupling constant (Hz).
Data for 13C-NMR are reported in terms of chemical shift (δ ppm), multiplicity, and
coupling constant (Hz). Gas chromatographic (GC) analysis was acquired on a
Shimadzu GC-2014 Series GC System equipped with a flame-ionization detector.
GC-MS analysis was performed either on Thermo Scientific AS 3000 Series GC-MS
System or Agilent 6890N gas chromatograph coupled to an Agilent 5973 inert mass
selective detector. HRMS analysis was performed on Finnigan LCQ advantage Max
Series MS System. Elementary Analysis was carried out on Elementar Vario EL III
elemental analyzer.
Page S2
Supporting Information
II. Preparation of Substrates
a. Preparation of propargyl phosphates
Propargyl phosphates were prepared according to literature procedure. [1]
A 50 mL round-bottom flask charged with anhydrous CH2Cl2 (15 mL), propargy
alcohol (10 mmol) and pyridine (2.5 equiv), DMAP (N, N-dimethyl-4-aminopyridine,
10 mol %) was added,and the mixture was cooled with an ice bath. To the solution,
diethylchlorophosphate (12 mmol, 1.1 equiv) was added dropwise and the mixture
was stirred at 0 ºC for 10 min. The mixture was allowed to warm up to room
temperature and stirred overnight at room temperature. The resulting mixture was
diluted with DCM (15 mL) and washed with water (10 mL ×2). The organic layer was
dried over MgSO4. After filtration and removal of the solvents in vacuo, distillation
gave propargyl phosphates.
b. Preparation of propargyl chlorides
A 50 mL round-bottom flask charged with anhydrous CH2Cl2 (15 mL), propargy
alcohol (10 mmol) and Pyridine (1.2 equiv), and the mixture was cooled with an ice
bath. To the solution, SOCl2 (12 mmol, 1.1 equiv) was added dropwise and the
mixture was stirred at 0 ºC for 10 min. The mixture was allowed to warm up to room
temperature and stirred overnight at room temperature. The resulting mixture was
diluted with ether (20 mL) and washed with 1N HCl solution (15 mL × 3). The water
layer was extracted with Et2O (20 mL × 3). The combined organic extracts were
washed with saturated NaHCO3 aq. (15 mL × 3). The organic layer was dried over
MgSO4. After filtration and removal of the solvents in vacuo, distillation gave
propargyl chlorides.
c. Preparation of mono- and di-deuterated gem-diborylalkanes
1, 1-Diborylalkanes were prepared according to literature procedure. [2]
Method A. In air, CuI (10 mmol, 1900 mg), MeOLi (30 mmol, 1140 mg), and
diboron reagent (22 mmol, 5588 mg) were added to a Schlenk tube equipped with a
stir bar. The vessel was evacuated and filled with argon (three cycles). DMF (60 mL),
and Dibromomethane (10mmol, 1740 mg) were added via syringe under an argon
Page S3
Supporting Information
atmosphere. The reaction mixture was stirred at 40 oC for 24 h, and then diluted with
EtOAc, filtered through silica gel with copious washings (Et2O or EtOAc),
concentrated, and purified by column chromatography, 1, 1-Diborylalkane (1) was
obtained.
Method B. In air, Cu-catalyst (10 mmol, 1900 mg), MeOLi (30 mmol, 1140 mg), and
diboron reagent (22 mmol, 5588 mg) were added to a Schlenk tube equipped with a
stir bar. The vessel was evacuated and filled with argon (three cycles). DMF (60 mL),
and Dibromomethane-d2 (10mmol, 1760 mg) were added via syringe under an argon
atmosphere. The reaction mixture was stirred at 40 oC for 24 h, and then diluted with
EtOAc, filtered through silica gel with copious washings (Et2O or EtOAc),
concentrated, and purified by column chromatography, di-deuterated gem-
diborylalkanes (2) was obtained.
B
BDD
OO
OO
Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane-d2 (2).
Following general procedure C, 1 was used, the product was isolated by flash
chromatography (1% ethyl acetate/hexane) as white solid, (1890 mg, 70%).
1H NMR (400 MHz, CDCl3) δ 1.23 (s, 24H).
Page S4
Supporting Information
III. Copper-Catalyzed Propargylation Reaction of
Diborylmethane
Experimental Procedures for Examples Described in Table 1.
In air, Cu-catalyst, base, ligand, were added to a Schlenk tube equipped with a stir bar.
The vessel was evacuated and filled with argon (three cycles). Solvent (1.0 mL) was
added in turn by syringe under argon atmosphere at room temperature, and then
stirred at 60 oC for 10 min. Then diborylmethane was added in turn under an argon
atmosphere and stirred at 60 oC for 10 min. And propargyl phosphates were added in
turn under an argon atmosphere. The reaction mixture was stirred at 60 oC for 24 h,
then diluted with EtOAc, filtered through silica gel with copious washings (Et2O or
EtOAc), and Triphenylmethane (36.6 mg, 0.15 mmol) was added as internal standard.
The product yield was determined by GC.
B O
O
4,4,5,5-tetramethyl-2-(4-phenylbut-3-yn-1-yl)-1,3,2-dioxaborolane (1b).Following general procedure A, 1a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (43mg, 83%).1H NMR (400 MHz, CDCl3) δ 7.34 – 7.25 (m, 2H), 7.23 – 7.12 (m, 3H), 2.44 (t, J = 7.6 Hz, 2H), 1.19 (s, 12H), 1.07 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 131.68, 128.31, 127.55, 124.38, 92.11, 83.50, 80.05, 25.01, 14.34.11B NMR (128 MHz, CDCl3) δ 33.49.HRMS (APCI) calcd for C16H2O2B+ [(M+H)+]: 257.1707; found: 257.1709.
Experimental Procedures for Examples Described in Table2.General Procedure A. In air, CuI 10 mol%, t-BuOLi 3 equiv, PPh3 20 mol%, were
added to a Schlenk tube equipped with a stir bar. The vessel was evacuated and filled
with argon (three cycles). THF (1.0 mL) was added in turn by syringe under argon
atmosphere at room temperature, and then stirred at 60 oC for 10 min. Then
diborylmethane (1) was added in turn under an argon atmosphere and stirred at 60 oC
Page S5
Supporting Information
for 10 min. And propargyl phosphates (0.2 mmol) were added in turn under an argon
atmosphere. The reaction mixture was stirred at 60 oC for 24 h. The reaction mixture
was then diluted with EtOAc, filtered through silica gel with copious washings (Et2O
or EtOAc), concentrated, and purified by column chromatography.
B O
O
O
2-(4-(4-methoxyphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2b).Following general procedure A, 2a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (36mg, 62%).1H NMR (400 MHz, CDCl3) δ 7.17 (t, J = 7.9 Hz, 1H), 6.97 (d, J = 7.5 Hz, 1H), 6.91 (s, 1H), 6.81 (dd, J = 8.3, 2.0 Hz, 1H), 3.78 (s, 3H), 2.51 (t, J = 7.6 Hz, 2H), 1.26 (s, 12H), 1.14 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 159.40, 129.37, 125.41, 124.28, 116.51, 114.25, 92.03, 83.54, 80.00, 55.41, 29.54, 25.03, 14.35.11B NMR (128 MHz, CDCl3) δ 33.53.HRMS (APCI) calcd for C16H22O2B+ [(M+H)+]: 287.1813; found: 287.1815
B O
O
O
2-(4-(4-methoxyphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (3b).Following general procedure A, 3a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (40mg, 70%).1H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.6 Hz, 2H), 6.79(d, J = 8.6 Hz, 2H), 3.78(s, 3H), 2.49 (t, J = 7.6 Hz, 2H), 1.25 (s, 12H), 1.13 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 159.08, 133.01, 116.58, 113.93, 90.46, 83.49, 79.76, 55.43, 25.02, 14.34. 11B NMR (128 MHz, CDCl3) δ 33.53.HRMS (APCI) calcd for C16H22O2B+ [(M+H)+]: 287.1813; found: 287.1813.
Page S6
Supporting Information
B O
O
O
2-(4-(4-ethoxyphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (4b).Following general procedure A, 4a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (41mg, 68%).1H NMR (400 MHz, CDCl3) δ 7.34 – 7.18 (m, 2H), 6.76 (d, J = 8.7 Hz, 2H), 3.99 (q, J = 7.0 Hz, 2H), 2.47 (t, J = 7.6 Hz, 2H), 1.38 (t, J = 7.0 Hz, 3H), 1.24 (s, 12H), 1.11 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 158.45, 132.97, 116.36, 114.43, 90.33, 83.45, 79.80, 63.57, 25.00, 14.97, 14.32.11B NMR (128 MHz, CDCl3) δ 32.77.HRMS (APCI) calcd for C18H25BO3
+ [(M+H)+]: 301.1970; found: 301.1970.
B O
O
4,4,5,5-tetramethyl-2-(4-(o-tolyl)but-3-yn-1-yl)-1,3,2-dioxaborolane (5b)Following general procedure A, 5a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (37mg, 68%).1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 7.5 Hz, 1H), 7.15 (dd, J = 4.3, 0.9 Hz, 2H), 7.11 – 7.05 (m, 1H), 2.56 (t, J = 7.6 Hz, 2H), 2.41 (s, 3H), 1.26 (s, 12H), 1.17 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 140.16, 131.91, 129.40, 127.54, 125.53, 96.15, 83.51, 78.91, 25.0, 20.92, 14.48.11B NMR (128 MHz, CDCl3) δ 33.98.HRMS (APCI) calcd for C17H23BO2
+ [(M+H)+]: 271.1864; found: 271.1872.
B O
O
4,4,5,5-tetramethyl-2-(4-(p-tolyl)but-3-yn-1-yl)-1,3,2-dioxaborolane (6b).Following general procedure A, 6a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (43mg, 79%).1H NMR (400 MHz, CDCl3) δ 7.26 (t, J = 4.0 Hz, 2H), 7.15 – 6.95 (m, 2H), 2.50 (t, J
Page S7
Supporting Information
= 7.6 Hz, 2H), 2.32 (s, 3H), 1.26 (s, 12H), 1.13 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 137.50, 131.57, 129.09, 121.31, 91.29, 83.51, 80.08, 29.92, 25.03, 21.60, 14.36.11B NMR (128 MHz, CDCl3) δ 33.95.HRMS (APCI) calcd for C17H23BO2
+ [(M+H)+]: 271.1864; found: 271.1853.
B O
O
2-(4-(3,5-dimethylphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (7b).Following general procedure A, 7a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (47mg, 83%).1H NMR (400 MHz, CDCl3) δ 7.01 (s, 2H), 6.88 (s, 1H), 2.49 (t, J = 7.7 Hz, 2H), 2.26 (s, 6H), 1.26 (s, 12H), 1.13 (t, J = 7.7 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 137.81, 129.48, 129.41, 123.98, 91.37, 83.50, 80.27, 25.03, 21.30, 14.34.11B NMR (128 MHz, CDCl3) δ 33.82.HRMS (APCI) calcd for C18H25BO2
+ [(M+H)+]: 285.2020; found:285.2024.
B O
O
Cl
2-(4-(4-chlorophenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (8b).Following general procedure A, 8a was used, (50mg, 86%). The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil.1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 2.50 (t, J = 7.6 Hz, 2H), 1.26 (s, 12H), 1.13 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 133.47, 132.93, 128.64, 122.90, 93.22, 83.56, 79.03, 25.02, 14.35.11B NMR (128 MHz, CDCl3) δ 34.03.HRMS (APCI) calcd for C16H20BClO2
+ [(M+H)+]: 291.1318; found:291.1322.
B O
O
Br
Page S8
Supporting Information
2-(4-(4-bromophenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (9b).Following general procedure A, 9a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (50mg, 75%).1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 8.6 Hz, 2H), 7.22 (d, J = 8.5 Hz, 2H), 2.49 (t, J = 7.6 Hz, 2H), 1.25 (s, 12H), 1.13 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 133.18, 131.56, 123.36, 121.64, 93.44, 83.56, 79.09, 25.01, 14.37.11B NMR (128 MHz, CDCl3) δ 33.56.HRMS (APCI) calcd for C16H20BBrO2
+ [(M+H)+]: 335.0812; found: 335.0812.
B O
O
F3CO
4,4,5,5-tetramethyl-2-(4-(4-(trifluoromethoxy)phenyl)but-3-yn-1-yl)-1,3,2-dioxaborolane (10b).Following general procedure A, 10a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (40mg, 59%).1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.7 Hz, 2H), 7.11 (d, J = 8.2 Hz, 2H), 2.50 (t, J = 7.6 Hz, 2H), 1.26 (s, 12H), 1.13 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 148.42, 133.10, 123.25, 121.87, 120.92, 93.14, 83.56, 83.04, 78.75, 25.00, 14.31.11B NMR (128 MHz, CDCl3) δ 33.56.HRMS (APCI) calcd for C17H21BF3O3
+ [(M+H)+]: 341.1530; found: 341.1535.
B O
O
OO
2-(4-(benzo[d][1,3]dioxol-5-yl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (11b).Following general procedure A, 11a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (37mg, 62%).1H NMR (400 MHz, CDCl3) δ 6.87 (dd, J = 8.0, 1.2 Hz, 1H), 6.81 (d, J = 1.1 Hz, 1H), 6.69 (d, J = 8.0 Hz, 1H), 5.92 (s, 2H), 2.46 (t, J = 7.6 Hz, 2H), 1.24 (s, 12H), 1.10 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 147.41, 147.30, 125.98, 117.72, 111.81, 108.46, 101.29, 90.31, 83.51, 79.78, 25.03, 14.30.11B NMR (128 MHz, CDCl3) δ 33.85.
Page S9
Supporting Information
HRMS (APCI) calcd for C17H21BO4+ [(M+H)+]: 301.1606; found: 301.1605.
B O
O
S4,4,5,5-tetramethyl-2-(4-(thiophen-2-yl)but-3-yn-1-yl)-1,3,2-dioxaborolane (12b).Following general procedure A, 12a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (43mg, 82%).1H NMR (400 MHz, CDCl3) δ 7.14 (dd, J = 5.2, 0.8 Hz, 1H), 7.08 (d, J = 3.1 Hz, 1H), 6.99 – 6.79 (m, 1H), 2.52 (t, J = 7.6 Hz, 2H), 1.27 (d, J = 7.1 Hz, 12H), 1.13 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 130.96, 126.91, 125.95, 96.17, 83.58, 73.23, 25.03, 14.63.11B NMR (128 MHz, CDCl3) δ 33.59.HRMS (APCI) calcd for C14H20BO2S+ [(M+H)+]:263.1272; found: 263.1272.
B O
O
O2-(4-(furan-2-yl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (13b).Following general procedure A, 13a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as pale yellow oil, (30mg, 60%).1H NMR (400 MHz, CDCl3) δ 7.31 (s, 1H), 6.43 (d, J = 3.5 Hz, 1H), 6.33 (d, J = 1.9 Hz, 1H), 2.53 (t, J = 7.7 Hz, 2H), 1.26 (s, 12H), 1.13 (t, J = 7.9 Hz, 2H).11B NMR (128 MHz, CDCl3) δ 33.94.13C NMR (101 MHz, CDCl3) δ 142.78, 137.95, 113.69, 110.78, 96.40, 83.34, 83.06, 70.46, 32.07, 25.00, 14.42. 11B NMR (128 MHz, CDCl3) δ 33.94.HRMS (APCI) calcd for C14H20BO3
+ [(M+H)+]: 247.1500; found:247.1503.
Experimental Procedures for Examples Described in Table 3.General Procedure B. In air, CuI 10 mol%, t-BuOLi 3 equiv, PPh3 20 mol%, were added to a Schlenk tube equipped with a stir bar. The vessel was evacuated and filled with argon (three cycles). THF (1.0 mL) was added in turn by syringe under argon atmosphere at room temperature, and then stirred at 60 oC for 10 min. Then diborylmethane (1) was added in turn under an argon atmosphere and stirred at 60 oC for 10 min. And propargyl phosphates (0.2 mmol) were added in turn under an argon atmosphere. The reaction mixture was stirred at 60 oC for 24 h. The reaction mixture was then diluted with EtOAc, filtered through silica gel with copious washings (Et2O or EtOAc), concentrated, and purified by column chromatography.
Page S10
Supporting Information
B O
O
4,4,5,5-tetramethyl-2-(pent-3-yn-1-yl)-1,3,2-dioxaborolane (16b).Following general procedure B, 16a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (23mg, 58%).1H NMR (400 MHz, CDCl3) δ 2.27 – 2.15 (m, 2H), 1.75 (t, J = 2.5 Hz, 3H), 1.25 (s, 12H), 1.01 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 83.40, 81.06, 74.95, 24.98, 13.61, 3.70.11B NMR (128 MHz, CDCl3) δ 33.85.HRMS (APCI) calcd for C11H20BO2
+ [(M+H)+]: 195.1551; found:195.1553.
B O
O
2-(hex-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (17b).Following general procedure B, 17a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (25mg, 60%).1H NMR (400 MHz, CDCl3) δ 2.24-2.15 (m, 2H), 2.15-2.10 (m, 2H), 1.25 (s, 12H), 1.09 (t, J = 7.5 Hz, 3H), 1.01 (t, J = 7.6 Hz, 2H).13C NMR (101 MHz, CDCl3) δ 83.39, 81.23, 81.13, 29.92, 24.99, 14.53, 13.63, 12.6.11B NMR (128 MHz, CDCl3) δ 33.85.HRMS (APCI) calcd for C12H22BO2
+ [(M+H)+]: 209.1707; found: 209.1706.
B O
O
4,4,5,5-tetramethyl-2-(non-3-yn-1-yl)-1,3,2-dioxaborolane (18b).Following general procedure B, 18a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (25mg, 50%).1H NMR (400 MHz, CDCl3) δ 2.30 – 2.20 (m, 2H), 2.16 – 2.07 (m, 2H), 1.53 – 1.41 (m, 2H), 1.38 – 1.30 (m, 4H), 1.25 (s, 12H), 1.01 (t, J = 7.6 Hz, 2H), 0.88 (t, J = 7.0 Hz, 3H).13C NMR (101 MHz, CDCl3) δ 83.37, 81.86, 79.77, 31.28, 29.05, 24.99, 22.46, 18.96, 14.21, 13.66.11B NMR (128 MHz, CDCl3) δ 33.73.HRMS (APCI) calcd for C15H28BO2
+ [(M+H)+]: 251.2117; found: 251.2117.
Page S11
Supporting Information
B O
O
Si
trimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-1-yn-1-yl)silane (19b).Following general procedure B, 19a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (27mg, 54%).1H NMR (400 MHz, CDCl3) δ 2.29 (t, J = 7.5 Hz, 2H), 1.22 (s, 12H), 1.01 (t, J = 7.5 Hz, 2H), 0.10 (s, 9H).13C NMR (101 MHz, CDCl3) δ 109.33, 83.54, 83.48, 25.00, 14.75, 0.36.11B NMR (128 MHz, CDCl3) δ 33.77.HRMS (APCI) calcd for C13H26BO2Si+ [(M+H)+]: 253.1790; found: 253.1804.
B O
O
OSi
tert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-2-yn-1-yl)oxy)silane (20b).Following general procedure B, 20a was used. The product was isolated by flash chromatography (2% ethyl acetate/hexane) as colorless oil, (43mg, 66%).1H NMR (400 MHz, CDCl3) δ 4.28 (t, J = 2.1 Hz, 2H), 2.29 (d, J = 8.0 Hz, 2H), 1.24 (s, 12H), 1.04 (t, J = 7.8 Hz, 2H), 0.90 (s, 9H), 0.10 (s, 6H).13C NMR (101MHz, CDCl3) δ 87.16, 83.48, 78.09, 52.24, 26.10, 25.01, 18.54, 13.68, 1.24, 0.21, -4.87.11B NMR (128 MHz, CDCl3) δ 33.92.HRMS (APCI) calcd forC17H34BO3Si+ [(M+H)+]: 325.2365; found: 325.2368.
Experimental Procedures for Examples Described in Table 4In air, Cu-catalyst, base, ligand, were added to a Schlenk tube equipped with a stir bar.
The vessel was evacuated and filled with argon (three cycles). Solvent (1.0 mL) was
added in turn by syringe under argon atmosphere at room temperature, and then
stirred at 60 oC for 10 min. Then diborylmethane was added in turn under an argon
atmosphere and stirred at 60 oC for 10 min. And cinnamyl electrophiles (X =
OPO(OEt)2, OBoc or Cl, 0.2mmol) were added in turn under an argon atmosphere.
The reaction mixture was stirred at 60 oC for 24 h, then diluted with EtOAc, filtered
through silica gel with copious washings (Et2O or EtOAc), and triphenylmethane
Page S12
Supporting Information
(36.6 mg, 0.15 mmol) was added as internal standard. The product yield was
determined by GC.
Experimental Procedures for Examples Described in Table 5General Procedure C. In air, CuI 10 mol%, t-BuOLi 6 equiv, PPh3 20 mol%, were
added to a Schlenk tube equipped with a stir bar. The vessel was evacuated and filled
with argon (three cycles). THF (1.0 mL) was added in turn by syringe under argon
atmosphere at room temperature, and then stirred at 60 oC for 10 min. Then
diborylmethane (1) was added in turn under an argon atmosphere and stirred at 60 oC
for 10 min. And propargyl chlorides (0.2 mmol) were added in turn under an argon
atmosphere. The reaction mixture was stirred at 60 oC for 24 h. The reaction mixture
was then diluted with EtOAc, filtered through silica gel with copious washings (Et2O
or EtOAc), concentrated and purified by column chromatography.
B O
O
O
2-(4-(4-methoxyphenyl)-2-methylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1d).Following general procedure C, 1c was used. The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil, (38mg, 63%).1H NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.8 Hz, 2H), 6.79 (d, J = 8.8 Hz, 2H), 3.79 (s, 3H), 2.89 (dd, J = 14.4, 7.2 Hz, 1H), 1.28 (d, J = 2.6 Hz, 3H), 1.25 (s, 12H), 1.17 -1.14 (m, 2H).13C NMR (101MHz, CDCl3) δ 159.98, 152.75, 133.53, 114.56, 114.03, 85.91, 85.18, 82.76, 64.08, 55.45, 53.64, 27.96, 21.85.11B NMR (128 MHz, CDCl3) δ 33.85.HRMS (APCI) calcd forC17H24BO2+ [(M+H)+]: 301.1970; found: 301.1970.
Page S13
Supporting Information
Me
Me
O
O
(Z)-(3-ethylidenehepta-1,4,5-triene-2,4-diyl)dibenzene (1f).Following general procedure C, 1c was used, CH3CN as solvent. The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil, (47mg, 70%).1H NMR (400 MHz, CDCl3) δ 7.38 – 7.22 (m, 4H), 6.86 (t, J = 8.9 Hz, 4H), 5.79 (dd, J = 7.0 Hz, 1H), 5.48 (dd, J = 14.3, 7.1 Hz, 1H), 5.25 (s, 1H), 5.00 (s, 1H), 3.81 (d, J = 12.3 Hz, 6H), 1.78 (d, J = 7.1 Hz, 3H), 1.73 (d, J = 6.8 Hz, 3H).13C NMR (101 MHz, CDCl3) δ 204.50, 158.80, 158.41, 148.69, 138.36, 134.22, 129.99, 129.46, 128.62, 127.44, 114.81, 113.84, 102.90, 87.62, 55.28, 15.53, 13.85.HRMS (APCI) calcd for C23H25O2
+ [(M+H)+]: 333.1849; found: 333.1848.
B O
O
4,4,5,5-tetramethyl-2-(2-methyl-4-phenylbut-3-yn-1-yl)-1,3,2-dioxaborolane (2d).Following general procedure C, 2c was used. The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil, (40mg, 74%). 1H NMR (400 MHz, CDCl3) δ 7.43 – 7.33 (m, 2H), 7.25-7.23 (m, 3H), 2.94 – 2.80 (m, 1H), 1.29 (d, J = 6.9 Hz, 3H), 1.26 (s, 12H), 1.12 -1.05 (m, 2H).13C NMR (101 MHz, CDCl3) δ 131.72, 128.29, 127.52, 124.40, 96.22, 83.43, 79.95, 25.03, 23.68, 22.69.11B NMR (128 MHz, CDCl3) δ 33.44HRMS (APCI) calcd for C17H24BO2
+ [(M+H)+]: 271.1864; found: 271.1848.
B O
O
F3CO
4,4,5,5-tetramethyl-2-(2-methyl-4-(4-(trifluoromethoxy)phenyl)but-3-yn-1-yl)-
1,3,2-dioxaborolane (3d).Following general procedure C, 3c was used. The product was isolated by flash
Page S14
Supporting Information
chromatography (1% ethyl acetate/hexane) as colorless oil, (33mg, 47%).1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.4 Hz, 2H), 7.10 (d, J = 8.5 Hz, 2H), 2.89 (dd, J = 14.1, 6.9 Hz, 1H), 1.28 (d, J = 7.0 Hz, 3H), 1.25 (s, 12H), 1.14-1.05 (m, 2H).11B NMR (128 MHz, CDCl3) δ 32.77.13C NMR (101 MHz, CDCl3) δ 133.12, 123.25, 120.90, 83.47, 29.54, 25.03, 23.55, 22.65.HRMS (APCI) calcd for C18H23BF3O3
+ [(M+H)+]: 355.1687; found: 355.1705.
B O
O
Br
2-(4-(4-bromophenyl)-2-methylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (4d).Following general procedure C, 4c was used. The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil, (38mg, 55%).1H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 8.3 Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 2.88 (dd, J = 14.3, 7.1 Hz, 1H), 1.28 (d, J = 6.9 Hz, 3H), 1.25 (s, 12H), 1.17-1.05 (m, 2H)13C NMR (101 MHz, CDCl3) δ 133.20, 131.52, 128.76, 121.59, 97.49, 83.46, 78.99, 25.06, 24.99, 23.52, 22.72.11B NMR (128 MHz, CDCl3) δ34.03.HRMS (APCI) calcd for C17H23BBrO2
+ [(M+H)+]: 349.0969; found: 349.0975.
B O
O
2-(2-ethyl-4-phenylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (5d).Following general procedure C, 5c was used. The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil, (33mg, 58%).13C NMR (101 MHz, CDCl3) δ 131.53, 128.07, 127.27, 124.31, 94.69, 83.21, 80.96, 30.52, 29.63, 24.91, 24.73, 11.93.11B NMR (128 MHz, CDCl3) δ 34.01.HRMS (APCI) calcd for C18H26BO2
+ [(M+H)+]: 285.2020; found: 285.2020.
Page S15
Supporting Information
B O
O
4,4,5,5-tetramethyl-2-(2-(phenylethynyl)pentyl)-1,3,2-dioxaborolane (6d).Following general procedure C, 6c was used, (32mg, 54%). The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil.1H NMR (400 MHz, CDCl3) δ 7.39 – 7.33 (m, 2H), 7.24 (d, J = 1.7 Hz, 3H), 2.85 – 2.69 (m, 1H), 1.57 – 1.40 (m, 4H), 1.26 (s, 12H), 1.11 (dd, J = 9.4, 7.7 Hz, 2H), 0.94 (t, J = 7.1 Hz, 3H).13C NMR (101 MHz, CDCl3) δ 131.73, 128.28, 127.47, 124.52, 95.10, 83.43, 81.01, 40.03, 27.95, 25.11, 24.95, 20.90, 14.19.11B NMR (128 MHz, CDCl3) δ 33.94.HRMS (APCI) calcd for C19H28BO2
+ [(M+H)+]: 299.2177; found: 299.2177.
B O
O
2-(2-isopropyl-4-phenylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(7d).Following general procedure C, 7c was used. The product was isolated by flash chromatography (1% ethyl acetate/hexane) as colorless oil, (30mg, 50%).1H NMR (400 MHz, CDCl3) δ 7.45 – 7.34 (m, 2H), 7.29 – 7.11 (m, 3H), 2.70 (dt, J = 10.5, 5.4 Hz, 1H), 1.73 (td, J = 13.3, 6.7 Hz, 1H), 1.26 (s, 12H), 1.12 (d, J = 10.4 Hz, 2H), 1.02 (t, J = 6.7 Hz, 6H).13C NMR (101 MHz, CDCl3) δ131.73, 128.28, 127.44, 124.61, 93.50, 83.44, 82.12, 35.03, 33.80, 25.19, 24.86, 21.18, 18.66.11B NMR (128 MHz, CDCl3) δ 34.37.HRMS (APCI) calcd for C19H28BO2
+ [(M+H)+]: 299.2177; found: 299.2177.
Experimental Procedures for Examples Described in Scheme2.General Procedure D. In air, CuI 10 mol%, t-BuOLi 3 equiv, PPh3 20 mol%, were added to a Schlenk tube equipped with a stir bar. The vessel was evacuated and filled with argon (three cycles). THF (1.0 mL) was added in turn by syringe under argon atmosphere at room temperature, and then stirred at 60 oC for 10 min. Then deuterated gem-diborylalkanes was added in turn under an argon atmosphere and stirred at 60 oC for 10 min. And propargyl phosphates (0.2 mmol) were added in turn under an argon atmosphere. The reaction mixture was stirred at 60 oC for 24 h. The reaction mixture was then diluted with EtOAc, filtered through silica gel with copious washings (Et2O or EtOAc), concentrated, and purified by column chromatography.
Page S16
Supporting Information
B O
O
D
D
4,4,5,5-tetramethyl-2-(4-phenylbut-3-yn-1-yl-1,1-d2)-1,3,2-dioxaborolane (2e).Following general procedure D, 1a and di-deuterated gem-diborylalkanes was used. The product was isolated by flash chromatography (1% ethyl acetate /hexane) as colorless oil, (45mg, 87%).1H NMR (400 MHz, CDCl3) δ 7.47 – 7.35 (m, 2H), 7.28 – 7.20 (m, 3H), 2.51 (s, 2H), 1.27 (s, 12H).13C NMR (101 MHz, CDCl3) δ 131.70, 128.33, 127.56, 124.39, 92.12, 83.52, 80.06, 25.03, 14.20.11B NMR (128 MHz, CDCl3) δ 33.90.HRMS (APCI) calcd for C16H20D2BO2
+ [(M+H)+]: 259.1883; found: 259.1836.
Page S17
Supporting Information
IV. References
[1] K. Semba, N. Bessho, T. Fujihara, J. Terao, Y. Tsuji, Angew. Chem. Int. Ed. 2014,
53, 9007.
[2] Z.-Q. Zhang, C.-T. Yang, L.-J. Liang, B. Xiao, X. Lu, J.-H. Liu, Y.-Y. Sun,
T. B. Marder, Y. Fu, Org. Lett. 2014, 16, 6342.
Page S18
Supporting Information
Ⅴ. NMR Spectra and Analysis1H NMR of bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane-d2 (2)
Page S19
Supporting Information
1H NMR, 13C NMR and 11B NMR of 2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)but-3-en-1-yl furan-2-carboxylate (1b)
Page S20
Supporting Information
1H NMR, 13C NMR and 11B NMR of 2-(4-(4-methoxyphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(2b)
Page S22
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(4-methoxyphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(3b)
Page S24
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(4-ethoxyphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(4b)
Page S26
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(4-(o-tolyl)but-3-yn-1-yl)-1,3,2-dioxaborolane(5b)
Page S28
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(4-(p-tolyl)but-3-yn-1-yl)-1,3,2-dioxaborolane(6b)
Page S30
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(3,5-dimethylphenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(7b)
Page S32
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(4-chlorophenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(8b)
Page S34
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(4-bromophenyl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(9b)
Page S36
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(4-(4-(trifluoromethoxy)phenyl)but-3-yn-1-yl)-1,3,2-dioxaborolane(10b)
Page S38
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(benzo[d][1,3]dioxol-5-yl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(11b)
Page S40
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(4-(thiophen-2-yl)but-3-yn-1-yl)-1,3,2-dioxaborolane(12b)
Page S42
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(furan-2-yl)but-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(13b)
Page S44
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(pent-3-yn-1-yl)-1,3,2-dioxaborolane(16b)
Page S46
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(hex-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(17b)
Page S48
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(non-3-yn-1-yl)-1,3,2-dioxaborolane(18b)
Page S50
Supporting Information
1H NMR, 13C NMR and 11B NMR oftrimethyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-1-yn-1-yl)silane(19b)
Page S52
Supporting Information
1H NMR, 13C NMR and 11B NMR oftert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-2-yn-1-yl)oxy)silane(20b)
Page S54
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(4-methoxyphenyl)-2-methylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(1d)
Page S56
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(2-methyl-4-phenylbut-3-yn-1-yl)-1,3,2-dioxaborolane(2d)
Page S58
Supporting Information
1H NMR and 13C NMR of (Z)-(3-ethylidenehepta-1,4,5-triene-2,4-diyl)dibenzene (1f).
Page S60
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(2-methyl-4-(4-(trifluoromethoxy)phenyl)but-3-yn-1-yl)-1,3,2-dioxaborolane(3d)
Page S61
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(4-(4-bromophenyl)-2-methylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(4d)
Page S63
Supporting Information
13C NMR and 11B NMR of2-(2-ethyl-4-phenylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(5d)
Page S65
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(2-(phenylethynyl)pentyl)-1,3,2-dioxaborolane(6d)
Page S66
Supporting Information
1H NMR, 13C NMR and 11B NMR of2-(2-isopropyl-4-phenylbut-3-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane(7d)
Page S68
Supporting Information
1H NMR, 13C NMR and 11B NMR of4,4,5,5-tetramethyl-2-(4-phenylbut-3-yn-1-yl-1,1-d2)-1,3,2-dioxaborolane(1e)
Page S70